Statement Of Financial Position [Abstract]

Biocartis Group NV - Filing #3122955

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
31,527 EUR
37,192 EUR
Intangible assets other than goodwill
4,770 EUR
5,067 EUR
Deferred tax assets
1,664 EUR
1,595 EUR
Cash and cash equivalents
26,125 EUR
53,522 EUR
123,668 EUR
Assets
114,277 EUR
142,480 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
220,302 EUR
220,657 EUR
Retained earnings
443,363 EUR
526,405 EUR
Share premium
631,722 EUR
711,874 EUR
Equity attributable to owners of parent
30,284 EUR
33,897 EUR
Equity
30,284 EUR
5,843 EUR
631,722 EUR
7,502 EUR
443,363 EUR
220,302 EUR
30,284 EUR
526,405 EUR
33,897 EUR
5,572 EUR
33,897 EUR
711,874 EUR
6,862 EUR
220,657 EUR
455,343 EUR
36,824 EUR
220,657 EUR
5,153 EUR
711,874 EUR
6,102 EUR
36,824 EUR
Equity and liabilities
114,277 EUR
142,480 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.